Literature DB >> 26156430

MYCNOS functions as an antisense RNA regulating MYCN.

Nadia Vadie1, Sheena Saayman, Alexandra Lenox, Amanda Ackley, Mathew Clemson, Jon Burdach, Jonathan Hart, Peter K Vogt, Kevin V Morris.   

Abstract

Amplification or overexpression of neuronal MYC (MYCN) is associated with poor prognosis of human neuroblastoma. Three isoforms of the MYCN protein have been described as well as a protein encoded by an antisense transcript (MYCNOS) that originates from the opposite strand at the MYCN locus. Recent findings suggest that some antisense long non-coding RNAs (lncRNAs) can play a role in epigenetically regulating gene expression. Here we report that MYCNOS transcripts function as a modulator of the MYCN locus, affecting MYCN promoter usage and recruiting various proteins, including the Ras GTPase-activating protein-binding protein G3BP1, to the upstream MYCN promoter. Overexpression of MYCNOS results in a reduction of upstream MYCN promoter usage and increased MYCN expression, suggesting that the protein-coding MYCNOS also functions as a regulator of MYCN ultimately controlling MYCN transcriptional variants. The observations presented here demonstrate that protein-coding transcripts can regulate gene transcription and can tether regulatory proteins to target loci.

Entities:  

Keywords:  G3BP1; MAP4; RNA; Transcriptional regulation; bidirectional promoter; neuroblastoma

Mesh:

Substances:

Year:  2015        PMID: 26156430      PMCID: PMC4615167          DOI: 10.1080/15476286.2015.1063773

Source DB:  PubMed          Journal:  RNA Biol        ISSN: 1547-6286            Impact factor:   4.652


  28 in total

1.  Nmi protein interacts with regions that differ between MycN and Myc and is localized in the cytoplasm of neuroblastoma cells in contrast to nuclear MycN.

Authors:  D Bannasch; I Weis; M Schwab
Journal:  Oncogene       Date:  1999-11-18       Impact factor: 9.867

2.  The precise chemical-physical nature of the pharmacore in FK506 binding protein inhibition: ElteX, a New class of nanomolar FKBP12 ligands.

Authors:  Maria Raffaella Martina; Eleonora Tenori; Marco Bizzarri; Stefano Menichetti; Gabriella Caminati; Piero Procacci
Journal:  J Med Chem       Date:  2013-01-24       Impact factor: 7.446

3.  Alternative processing of RNA transcribed from NMYC.

Authors:  L W Stanton; J M Bishop
Journal:  Mol Cell Biol       Date:  1987-12       Impact factor: 4.272

4.  Effects of a novel long noncoding RNA, lncUSMycN, on N-Myc expression and neuroblastoma progression.

Authors:  Pei Y Liu; Daniela Erriquez; Glenn M Marshall; Andrew E Tee; Patsie Polly; Mathew Wong; Bing Liu; Jessica L Bell; Xu D Zhang; Giorgio Milazzo; Belamy B Cheung; Archa Fox; Alexander Swarbrick; Stefan Hüttelmaier; Maria Kavallaris; Giovanni Perini; John S Mattick; Marcel E Dinger; Tao Liu
Journal:  J Natl Cancer Inst       Date:  2014-06-06       Impact factor: 13.506

5.  Many human large intergenic noncoding RNAs associate with chromatin-modifying complexes and affect gene expression.

Authors:  Ahmad M Khalil; Mitchell Guttman; Maite Huarte; Manuel Garber; Arjun Raj; Dianali Rivea Morales; Kelly Thomas; Aviva Presser; Bradley E Bernstein; Alexander van Oudenaarden; Aviv Regev; Eric S Lander; John L Rinn
Journal:  Proc Natl Acad Sci U S A       Date:  2009-07-01       Impact factor: 11.205

6.  Epigenetic silencing of tumour suppressor gene p15 by its antisense RNA.

Authors:  Wenqiang Yu; David Gius; Patrick Onyango; Kristi Muldoon-Jacobs; Judith Karp; Andrew P Feinberg; Hengmi Cui
Journal:  Nature       Date:  2008-01-10       Impact factor: 49.962

7.  p16(INK4a) translation suppressed by miR-24.

Authors:  Ashish Lal; Hyeon Ho Kim; Kotb Abdelmohsen; Yuki Kuwano; Rudolf Pullmann; Subramanya Srikantan; Ramesh Subrahmanyam; Jennifer L Martindale; Xiaoling Yang; Fariyal Ahmed; Francisco Navarro; Derek Dykxhoorn; Judy Lieberman; Myriam Gorospe
Journal:  PLoS One       Date:  2008-03-26       Impact factor: 3.240

8.  NCYM, a Cis-antisense gene of MYCN, encodes a de novo evolved protein that inhibits GSK3β resulting in the stabilization of MYCN in human neuroblastomas.

Authors:  Yusuke Suenaga; S M Rafiqul Islam; Jennifer Alagu; Yoshiki Kaneko; Mamoru Kato; Yukichi Tanaka; Hidetada Kawana; Shamim Hossain; Daisuke Matsumoto; Mami Yamamoto; Wataru Shoji; Makiko Itami; Tatsuhiro Shibata; Yohko Nakamura; Miki Ohira; Seiki Haraguchi; Atsushi Takatori; Akira Nakagawara
Journal:  PLoS Genet       Date:  2014-01-02       Impact factor: 5.917

9.  Regulation of MYCN expression in human neuroblastoma cells.

Authors:  Joannes F M Jacobs; Hans van Bokhoven; Frank N van Leeuwen; Christina A Hulsbergen-van de Kaa; I Jolanda M de Vries; Gosse J Adema; Peter M Hoogerbrugge; Arjan P M de Brouwer
Journal:  BMC Cancer       Date:  2009-07-18       Impact factor: 4.430

10.  Bidirectional transcription directs both transcriptional gene activation and suppression in human cells.

Authors:  Kevin V Morris; Sharon Santoso; Anne-Marie Turner; Chiara Pastori; Peter G Hawkins
Journal:  PLoS Genet       Date:  2008-11-14       Impact factor: 5.917

View more
  15 in total

1.  LncRNA MYCNOS facilitates proliferation and invasion in hepatocellular carcinoma by regulating miR-340.

Authors:  Junfeng Yu; Zhejian Ou; Yangyang Lei; Liuhua Chen; Qiao Su; Kunsong Zhang
Journal:  Hum Cell       Date:  2019-11-27       Impact factor: 4.174

Review 2.  The Origins and Functions of De Novo Genes: Against All Odds?

Authors:  Caroline M Weisman
Journal:  J Mol Evol       Date:  2022-04-22       Impact factor: 3.973

3.  RNA Directed Modulation of Phenotypic Plasticity in Human Cells.

Authors:  Laura Trakman; Chris Hewson; Jon Burdach; Kevin V Morris
Journal:  PLoS One       Date:  2016-04-15       Impact factor: 3.240

Review 4.  lncRNAs and MYC: An Intricate Relationship.

Authors:  Ingram Iaccarino
Journal:  Int J Mol Sci       Date:  2017-07-12       Impact factor: 5.923

5.  The long non-coding RNA MYCNOS-01 regulates MYCN protein levels and affects growth of MYCN-amplified rhabdomyosarcoma and neuroblastoma cells.

Authors:  Eleanor M O'Brien; Joanna L Selfe; Ana Sofia Martins; Zoë S Walters; Janet M Shipley
Journal:  BMC Cancer       Date:  2018-02-21       Impact factor: 4.430

6.  Insights into the Function of Long Noncoding RNAs in Sepsis Revealed by Gene Co-Expression Network Analysis.

Authors:  Diogo Vieira da Silva Pellegrina; Patricia Severino; Hermes Vieira Barbeiro; Heraldo Possolo de Souza; Marcel Cerqueira César Machado; Fabiano Pinheiro-da-Silva; Eduardo Moraes Reis
Journal:  Noncoding RNA       Date:  2017-01-26

Review 7.  In Silico and In Vitro Analyses of LncRNAs as Potential Regulators in the Transition from the Epithelioid to Sarcomatoid Histotype of Malignant Pleural Mesothelioma (MPM).

Authors:  Anand S Singh; Richard Heery; Steven G Gray
Journal:  Int J Mol Sci       Date:  2018-04-26       Impact factor: 5.923

8.  The interplay of long non-coding RNAs and MYC in cancer.

Authors:  Michael J Hamilton; Matthew D Young; Silvia Sauer; Ernest Martinez
Journal:  AIMS Biophys       Date:  2015-12-01

9.  Transcriptional gene silencing in humans.

Authors:  Marc S Weinberg; Kevin V Morris
Journal:  Nucleic Acids Res       Date:  2016-04-07       Impact factor: 16.971

10.  Dysregulated Pyrimidine Biosynthesis Contributes to 5-FU Resistance in SCLC Patient-Derived Organoids but Response to a Novel Polymeric Fluoropyrimidine, CF10.

Authors:  William H Gmeiner; Lance D Miller; Jeff W Chou; Anthony Dominijanni; Lysette Mutkus; Frank Marini; Jimmy Ruiz; Travis Dotson; Karl W Thomas; Graham Parks; Christina R Bellinger
Journal:  Cancers (Basel)       Date:  2020-03-26       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.